{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:32:05Z","timestamp":1777429925118,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FISR2020IP_04128"],"award-info":[{"award-number":["FISR2020IP_04128"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FISR2020IP_04128"],"award-info":[{"award-number":["FISR2020IP_04128"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2017XA5J5N"],"award-info":[{"award-number":["PRIN 2017XA5J5N"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-23670"],"award-info":[{"award-number":["IG-23670"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["CGGP11139B"],"award-info":[{"award-number":["CGGP11139B"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca"},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02364602"],"award-info":[{"award-number":["GR-2016-02364602"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As an inherited disorder characterized by severe pulmonary disease, cystic fibrosis could be considered a comorbidity for coronavirus disease 2019. Instead, current clinical evidence seems to be heading in the opposite direction. To clarify whether host factors expressed by the Cystic Fibrosis epithelia may influence coronavirus disease 2019 progression, here we describe the expression of SARS-CoV-2 receptors in primary airway epithelial cells. We show that angiotensin converting enzyme 2 (ACE2) expression and localization are regulated by Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) channel. Consistently, our results indicate that dysfunctional CFTR channels alter susceptibility to SARS-CoV-2 infection, resulting in reduced viral entry and replication in Cystic Fibrosis cells. Depending on the pattern of ACE2 expression, the SARS-CoV-2 spike (S) protein induced high levels of Interleukin 6 in healthy donor-derived primary airway epithelial cells, but a very weak response in primary Cystic Fibrosis cells. Collectively, these data support that Cystic Fibrosis condition may be at least partially protecting from SARS-CoV-2 infection.<\/jats:p>","DOI":"10.1038\/s41467-023-35862-0","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T07:03:30Z","timestamp":1673334210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6849-4487","authenticated-orcid":false,"given":"Valentino","family":"Bezzerri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-5497","authenticated-orcid":false,"given":"Valentina","family":"Gentili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Api","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Finotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9242-1766","authenticated-orcid":false,"given":"Chiara","family":"Papi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tamanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9982-4100","authenticated-orcid":false,"given":"Christian","family":"Boni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9143-8205","authenticated-orcid":false,"given":"Elena","family":"Baldisseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Olioso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Duca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-2496","authenticated-orcid":false,"given":"Monica","family":"Borgatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7108-6508","authenticated-orcid":false,"given":"Paolo","family":"Pinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Cabrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gambari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2285-9970","authenticated-orcid":false,"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Rimessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9507-9126","authenticated-orcid":false,"given":"Roberta","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-7248","authenticated-orcid":false,"given":"Marco","family":"Cipolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"35862_CR1","doi-asserted-by":"publisher","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell https:\/\/doi.org\/10.1016\/j.cell.2020.02.052 (2020).","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"35862_CR2","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"35862_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 203, 631\u2013637 (2004).","journal-title":"J. Pathol."},{"key":"35862_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","volume":"368","author":"JB Moore","year":"2020","unstructured":"Moore, J. B. & June, C. H. Cytokine release syndrome in severe COVID-19. Science 368, 473\u2013474 (2020).","journal-title":"Science"},{"key":"35862_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/08830185.2021.1884248","volume":"41","author":"Y Que","year":"2022","unstructured":"Que, Y. et al. Cytokine release syndrome in COVID-19: a major mechanism of morbidity and mortality. Int. Rev. Immunol. 41, 217\u2013230 (2022).","journal-title":"Int. Rev. Immunol."},{"key":"35862_CR6","doi-asserted-by":"publisher","unstructured":"Luo, M. et al. IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.139024 (2020).","DOI":"10.1172\/jci.insight.139024"},{"key":"35862_CR7","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","volume":"395","author":"MJ Cummings","year":"2020","unstructured":"Cummings, M. J. et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 395, 1763\u20131770 (2020).","journal-title":"Lancet"},{"key":"35862_CR8","doi-asserted-by":"publisher","first-page":"102214","DOI":"10.1016\/j.coph.2022.102214","volume":"64","author":"G Cabrini","year":"2022","unstructured":"Cabrini, G., Rimessi, A., Borgatti, M., Pinton, P. & Gambari, R. Overview of CF lung pathophysiology. Curr. Opin. Pharm. 64, 102214 (2022).","journal-title":"Curr. Opin. Pharm."},{"key":"35862_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jcf.2011.06.004","volume":"10","author":"L Viviani","year":"2011","unstructured":"Viviani, L., Assael, B. M. & Kerem, E., group, E. A. H. N. S. Impact of the A (H1N1) pandemic influenza (season 2009\u20132010) on patients with cystic fibrosis. J. Cyst. Fibros. 10, 370\u2013376 (2011).","journal-title":"J. Cyst. Fibros."},{"key":"35862_CR10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1080\/1040841X.2017.1297763","volume":"43","author":"L Billard","year":"2017","unstructured":"Billard, L. et al. Viruses in cystic fibrosis patients\u2019 airways. Crit. Rev. Microbiol 43, 690\u2013708 (2017).","journal-title":"Crit. Rev. Microbiol"},{"key":"35862_CR11","doi-asserted-by":"publisher","unstructured":"Berardis, S. et al. SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis. J. Cyst. Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2020.08.005 (2020).","DOI":"10.1016\/j.jcf.2020.08.005"},{"key":"35862_CR12","doi-asserted-by":"publisher","unstructured":"Corvol, H. et al. First wave of COVID-19 in French patients with cystic fibrosis. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9113624 (2020).","DOI":"10.3390\/jcm9113624"},{"key":"35862_CR13","doi-asserted-by":"publisher","first-page":"106062","DOI":"10.1016\/j.rmed.2020.106062","volume":"170","author":"P Mondejar-Lopez","year":"2020","unstructured":"Mondejar-Lopez, P. et al. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey. Respir. Med. 170, 106062 (2020).","journal-title":"Respir. Med."},{"key":"35862_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12890-022-01900-8","volume":"22","author":"A Jaudszus","year":"2022","unstructured":"Jaudszus, A. et al. One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis. BMC Pulm. Med. 22, 101 (2022).","journal-title":"BMC Pulm. Med."},{"key":"35862_CR15","doi-asserted-by":"publisher","first-page":"e0251527","DOI":"10.1371\/journal.pone.0251527","volume":"16","author":"C Colombo","year":"2021","unstructured":"Colombo, C. et al. SARS-CoV-2 infection in cystic fibrosis: a multicentre prospective study with a control group, Italy, February\u2013July 2020. PLoS One 16, e0251527 (2021).","journal-title":"PLoS One"},{"key":"35862_CR16","doi-asserted-by":"publisher","unstructured":"Naehrlich, L. et al. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020. J. Cyst. Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2021.03.017 (2021).","DOI":"10.1016\/j.jcf.2021.03.017"},{"key":"35862_CR17","doi-asserted-by":"publisher","unstructured":"Colombo, C. et al. Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society. Infection https:\/\/doi.org\/10.1007\/s15010-021-01737-z (2021).","DOI":"10.1007\/s15010-021-01737-z"},{"key":"35862_CR18","doi-asserted-by":"publisher","first-page":"00411","DOI":"10.1183\/23120541.00411-2021","volume":"7","author":"A Jung","year":"2021","unstructured":"Jung, A. et al. Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe. ERJ Open Res. 7, 00411\u201302021 (2021).","journal-title":"ERJ Open Res."},{"key":"35862_CR19","doi-asserted-by":"publisher","unstructured":"Braga, L. et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature https:\/\/doi.org\/10.1038\/s41586-021-03491-6 (2021).","DOI":"10.1038\/s41586-021-03491-6"},{"key":"35862_CR20","doi-asserted-by":"publisher","first-page":"28306","DOI":"10.1074\/jbc.M109.001669","volume":"284","author":"MH Chang","year":"2009","unstructured":"Chang, M. H. et al. Slc26a9 is inhibited by the R-region of the cystic fibrosis transmembrane conductance regulator via the STAS domain. J. Biol. Chem. 284, 28306\u201328318 (2009).","journal-title":"J. Biol. Chem."},{"key":"35862_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0014-5793(96)01414-7","volume":"400","author":"K Kunzelmann","year":"1997","unstructured":"Kunzelmann, K., Kiser, G. L., Schreiber, R. & Riordan, J. R. Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett. 400, 341\u2013344 (1997).","journal-title":"FEBS Lett."},{"key":"35862_CR22","doi-asserted-by":"publisher","first-page":"25377","DOI":"10.1074\/jbc.M201925200","volume":"277","author":"AA Konstas","year":"2002","unstructured":"Konstas, A. A., Koch, J. P., Tucker, S. J. & Korbmacher, C. Cystic fibrosis transmembrane conductance regulator-dependent up-regulation of Kir1.1 (ROMK) renal K+ channels by the epithelial sodium channel. J. Biol. Chem. 277, 25377\u201325384 (2002).","journal-title":"J. Biol. Chem."},{"key":"35862_CR23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.immuni.2017.11.010","volume":"47","author":"SA Riquelme","year":"2017","unstructured":"Riquelme, S. A. et al. Cystic fibrosis transmembrane conductance regulator attaches tumor suppressor PTEN to the membrane and promotes anti Pseudomonas aeruginosa Immunity. Immunity 47, 1169\u20131181.e1167 (2017).","journal-title":"Immunity"},{"key":"35862_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep27390","volume":"6","author":"MJ Watson","year":"2016","unstructured":"Watson, M. J. et al. The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) uses its C-terminus to regulate the A2B adenosine receptor. Sci. Rep. 6, 27390 (2016).","journal-title":"Sci. Rep."},{"key":"35862_CR25","doi-asserted-by":"publisher","first-page":"102770","DOI":"10.1016\/j.isci.2021.102770","volume":"24","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q., Gefter, J., Sneddon, W. B., Mamonova, T. & Friedman, P. A. ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion. iScience 24, 102770 (2021).","journal-title":"iScience"},{"key":"35862_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI0216112","volume":"110","author":"T Ma","year":"2002","unstructured":"Ma, T. et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J. Clin. Invest. 110, 1651\u20131658 (2002).","journal-title":"J. Clin. Invest."},{"key":"35862_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1165\/rcmb.2009-0361OC","volume":"44","author":"KE Scheckenbach","year":"2011","unstructured":"Scheckenbach, K. E. et al. Prostaglandin E2regulation of cystic fibrosis transmembrane conductance regulator activity and airway surface liquid volume requires gap junctional communication. Am. J. Respir. Cell Mol. Biol. 44, 74\u201382 (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"35862_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.jcf.2018.12.001","volume":"18","author":"HC Valley","year":"2019","unstructured":"Valley, H. C. et al. Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cells. J. Cyst. Fibros. 18, 476\u2013483 (2019).","journal-title":"J. Cyst. Fibros."},{"key":"35862_CR29","doi-asserted-by":"publisher","first-page":"C872","DOI":"10.1152\/ajpcell.00507.2010","volume":"301","author":"E Sondo","year":"2011","unstructured":"Sondo, E. et al. Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling. Am. J. Physiol.-Cell Physiol. 301, C872\u2013C885 (2011).","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"35862_CR30","doi-asserted-by":"publisher","first-page":"19797","DOI":"10.1074\/jbc.273.31.19797","volume":"273","author":"DB Short","year":"1998","unstructured":"Short, D. B. et al. An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton. J. Biol. Chem. 273, 19797\u201319801 (1998).","journal-title":"J. Biol. Chem."},{"key":"35862_CR31","doi-asserted-by":"publisher","unstructured":"Bortolotti, D. et al. TLR3 and TLR7 RNA sensor activation during SARS-CoV-2 infection. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms9091820 (2021).","DOI":"10.3390\/microorganisms9091820"},{"key":"35862_CR32","doi-asserted-by":"publisher","unstructured":"Fabbri, E. et al. A peptide nucleic acid against MicroRNA miR-145-5p enhances the expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in Calu-3 cells. Molecules https:\/\/doi.org\/10.3390\/molecules23010071 (2017).","DOI":"10.3390\/molecules23010071"},{"key":"35862_CR33","doi-asserted-by":"publisher","unstructured":"Tamanini, A. et al. A peptide-nucleic acid targeting miR-335-5p enhances expression of cystic fibrosis transmembrane conductance regulator. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines9020117 (2021).","DOI":"10.3390\/biomedicines9020117"},{"key":"35862_CR34","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ymthe.2020.02.001","volume":"28","author":"C De Santi","year":"2020","unstructured":"De Santi, C. et al. Precise targeting of miRNA sites restores CFTR activity in CF bronchial epithelial cells. Mol. Ther. 28, 1190\u20131199 (2020).","journal-title":"Mol. Ther."},{"key":"35862_CR35","doi-asserted-by":"publisher","unstructured":"Sultan, S. et al. A Peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3\u2019UTR of the cystic fibrosis transmembrane conductance regulator. Molecules https:\/\/doi.org\/10.3390\/molecules25071677 (2020).","DOI":"10.3390\/molecules25071677"},{"key":"35862_CR36","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.4049\/jimmunol.1202960","volume":"190","author":"IK Oglesby","year":"2013","unstructured":"Oglesby, I. K., Chotirmall, S. H., McElvaney, N. G. & Greene, C. M. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in \u0394F508 cystic fibrosis airway epithelium. J. Immunol. 190, 3354\u20133362 (2013).","journal-title":"J. Immunol."},{"key":"35862_CR37","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1002\/ppul.24129","volume":"53","author":"EA Roesch","year":"2018","unstructured":"Roesch, E. A., Nichols, D. P. & Chmiel, J. F. Inflammation in cystic fibrosis: an update. Pediatr. Pulmonol. 53, S30\u2013S50 (2018).","journal-title":"Pediatr. Pulmonol."},{"key":"35862_CR38","doi-asserted-by":"publisher","unstructured":"Majka, G. et al. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6. Clin. Exp. Immunol. https:\/\/doi.org\/10.1111\/cei.13624 (2021).","DOI":"10.1111\/cei.13624"},{"key":"35862_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ppul.20237","volume":"40","author":"C Colombo","year":"2005","unstructured":"Colombo, C. et al. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Pediatr. Pulmonol. 40, 15\u201321 (2005).","journal-title":"Pediatr. Pulmonol."},{"key":"35862_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jcf.2010.06.001","volume":"9","author":"H Makukh","year":"2010","unstructured":"Makukh, H. et al. A high frequency of the Cystic Fibrosis 2184insA mutation in Western Ukraine: Genotype\u2013phenotype correlations, relevance for newborn screening and genetic testing. J. Cyst. Fibros. 9, 371\u2013375 (2010).","journal-title":"J. Cyst. Fibros."},{"key":"35862_CR41","doi-asserted-by":"publisher","unstructured":"Lotti, V. et al. CFTR Modulation reduces SARS-CoV-2 infection in human bronchial epithelial cells. Cells https:\/\/doi.org\/10.3390\/cells11081347 (2022).","DOI":"10.3390\/cells11081347"},{"key":"35862_CR42","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"35862_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2007.02.007","volume":"128","author":"W Wang","year":"2007","unstructured":"Wang, W. et al. Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway. Virus Res. 128, 1\u20138 (2007).","journal-title":"Virus Res."},{"key":"35862_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.virusres.2009.01.005","volume":"142","author":"SF Dosch","year":"2009","unstructured":"Dosch, S. F., Mahajan, S. D. & Collins, A. R. SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro. Virus Res. 142, 19\u201327 (2009).","journal-title":"Virus Res."},{"key":"35862_CR45","doi-asserted-by":"publisher","first-page":"e21441","DOI":"10.1096\/fj.202001952R","volume":"35","author":"A Recchiuti","year":"2021","unstructured":"Recchiuti, A. et al. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages. FASEB J. 35, e21441 (2021).","journal-title":"FASEB J."},{"key":"35862_CR46","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1242\/jcs.089086","volume":"125","author":"S Monterisi","year":"2012","unstructured":"Monterisi, S. et al. CFTR regulation in human airway epithelial cells requires integrity of the actin cytoskeleton and compartmentalized cAMP and PKA activity. J. Cell Sci. 125, 1106\u20131117 (2012).","journal-title":"J. Cell Sci."},{"key":"35862_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7201","volume":"6","author":"A Rimessi","year":"2015","unstructured":"Rimessi, A. et al. Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis. Nat. Commun. 6, 6201 (2015).","journal-title":"Nat. Commun."},{"key":"35862_CR48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1113\/jphysiol.2005.096669","volume":"569","author":"Z Bebok","year":"2005","unstructured":"Bebok, Z. et al. Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers. J. Physiol. 569, 601\u2013615 (2005).","journal-title":"J. Physiol."},{"key":"35862_CR49","doi-asserted-by":"publisher","first-page":"C723","DOI":"10.1152\/ajpcell.00462.2010","volume":"300","author":"KW Dunn","year":"2011","unstructured":"Dunn, K. W., Kamocka, M. M. & McDonald, J. H. A practical guide to evaluating colocalization in biological microscopy. Am. J. Physiol. Cell Physiol. 300, C723\u2013C742 (2011).","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-35862-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-35862-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-35862-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T07:05:27Z","timestamp":1673334327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-35862-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35862"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-35862-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"9 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}